Pharmaceuticals business

Corbett Keeling advised a UK pharmaceuticals business on the confidential sale of one its assets.

Service
Sector
Year
2017
Close

Speciality European Pharma

Corbett Keeling advised the management team of Speciality European Pharma Limited (“SEP” ), on the acquisition of the speciality pharmaceutical and medical devices group from  its venture capital shareholders with the backing of Juno Pharmaceuticals Inc. (“Juno”), an international specialty pharmaceutical company and leading life science investor.

Headquartered in the UK, SEP is a speciality pharmaceutical and medical devices group that focuses on meeting the needs of the specialist physician. The Company was founded in 2006 and has grown rapidly over the past five years, with a commercial presence in much of Europe and a desire to grow beyond. The transaction provides the Company with the opportunity not only to continue its growth strategy with the existing products but also to invest for the long-term in the untapped potential in its proprietary development portfolio.

Commenting on the Management Buy-Out, Jim Keeling, Chairman of Corbett Keeling, said:

“Following the buy-out of SEP, the management team is extremely well placed to grow the business and realise the potential of its product portfolio. Together with backers, Juno, we wish them a successful future partnership.”

SEP Press release

 

 

“Corbett Keeling created a way forward, where others could not, at a critical moment for the management team. Their access to the appropriate funders in the UK and overseas, and their ability to move quickly, were both crucial to making this transaction possible.”

Patrick Banks, CEO of Speciality European Pharma

Service
Sector
Year
2016
Website
Close

Gee Lawson

Corbett Keeling advised the shareholders of Gee Lawson on the sale of the business to LEHVOSS UK Limited, the UK subsidiary of Germany-based Lehmann&VossCo.

Gee Lawson, founded in 1936 and employing 34 with its head office in London, is a leading specialist distributor of ingredients into the Nutritional and Chemical life science sectors across Europe and the US. The transaction is a strategic move that strengthens the LEHVOSS Group portfolio in the nutritional and life science sectors across Europe and globally.

Jim Keeling, who led the team advising Gee Lawson’s shareholders, commented “LEHVOSS UK, as a new owner, is a great match for Gee Lawson. We are delighted at the successful outcome.”

CK Press Release – Gee Lawson August 2015

“We saw in LEHVOSS UK a company with many of the key attributes we see in ourselves and it became an easy decision to sell to them. We were delighted with the advice and assistance we obtained from the Corbett Keeling team throughout the process in order to reach that point.”

Jonathan Shorts, Former Owner of Gee Lawson

Service
Sector
Year
2015
Close

Pharmaceuticals business

Corbett Keeling advised the owner of a UK pharmaceuticals business on its confidential sale to an overseas trade buyer.

“The sale of this pharmaceuticals business exemplifies the strength of Corbett Keeling's network of industry specialists working together with the core team to provide the best possible corporate finance advice to our clients.”

Andrew Dean, Head of Corbett Keeling's Healthcare team

Service
Sector
Year
2014
Close

Intrapharm Laboratories

Corbett Keeling advised Intrapharm Laboratories on raising debt funding in order to finance the company’s acquisition strategy.

Intrapharm Laboratories supplies both niche and branded pharmaceuticals to the NHS and international markets. Its team of professionals has many years of experience in the commercialisation of pharmaceutical products, taking them from registration to patient and thereby fostering a mutually beneficial relationship.


“Corbett Keeling's knowledge and understanding of the UK debt market and our contacts with the key decision makers enabled us to identify quickly and accurately the most appropriate source of debt funding for our client.”

Jim Keeling, Chairman and Chief Executive of Corbett Keeling

Service
Sector
Year
2014
Close

pH Associates

pH Associates, the market leading ‘Real World Data’ and ‘Market Access’ consultancy in the health sector, was sold to OPEN Health, a joint venture with global communications group Chime Communications Plc.  pH Associates was set up by Kate Peperell and Lesley Howell in 1999.

As the two founding shareholders started to consider an exit for the business they had created, they appointed Corbett Keeling and its partner firm Equiteq to carry out an Equity Growth Accelerator to assess how to grow revenue, build equity and sell the business at the right time for maximum value. Once they had reached this “right time”, Kate and Lesley appointed Corbett Keeling and Equiteq to advise them on the sale of their business.

 

“We are absolutely delighted with the deal, our new home with Chime and what that means for the future of our business. It's been a pleasure working with the Corbett Keeling/Equiteq team, their expertise in our sector and attention to detail was instrumental in making the deal happen with a win/win deal structure for both parties.”

Lesley Howell, Co-founding Director, PH Associates Ltd

Service
Sector
Year
2012
Website
Close

Home Choice Care

Home Choice Care, a provider of care to individuals in their own homes, undertook an acquisition search which resulted in the acquisition of Lilac Care Ltd, a provider of in-home care support services.

Corbett Keeling undertook the acquisition search on behalf of Home Choice Care. Home Choice Care was acquired by Westminster Homecare in November 2012.

Service
Sector
Year
2009
Website
Close

Gordon Laboratory Group

Gordon Laboratory Group, a provider of pathology services, raised development capital.

Corbett Keeling advised Gordon Laboratory on its fund raising.

Service
Sector
Year
2009
Website
Close

HCML

HCML, the UK’s leading independent provider of professional rehabilitation, case management and employment services to the insurance industry, solicitors and corporate clients, undertook a secondary management buy-out from 3i.

Corbett Keeling advised Helen Merfield, CEO and founder of HCML on all aspects of the buy-out, including arranging funding, agreeing terms and managing the whole process on behalf of the management team.

 

“Corbett Keeling were a breath of fresh air - they came highly recommended and I can see why. We were a young management team with no experience in selling a business or trying to achieve an MBO and it was initially quite daunting. Their approach was personal and it really felt like they were not only on our side but totally supporting us, ensuring we understood each step and what we could achieve. It was largely due to them that we achieved the MBO we wanted. I wouldn’t hesitate to recommend them to anyone and have already done so.”

Helen Merfield, CEO, HCML

Service
Sector
Year
2008
Website
Close

Taut International

Taut International BVI, a manufacturer of sports drinks, was sold to A. G. Barr Plc.

Corbett Keeling advised the shareholders of Taut International on the sale of their business.

Service
Sector
Year
2008
Website
Close

Healthcare Enterprise Group

Healthcare Enterprise Group Plc, an international healthcare services company focused on occupational healthcare, private healthcare services and distribution of medical devices, sold its subsidiary CICS, a supplier of medical and dental products, to Trycare Ltd, a supplier and distributor of products to the dental and chiropody markets.

Corbett Keeling advised Healthcare Enterprise Group on the sale of its subsidiary.

Service
Sector
Year
2007
Website
Close

WestawayGillis

WestawayGillis, a global healthcare market access consultancy, was sold to WPP Group Plc.

Corbett Keeling advised the shareholders of WestawayGillis, which now trades as The WG Group.

BUPA Healthcare Professionals

Advantage Healthcare, a leading healthcare services provider trading under the name BUPA Healthcare Professionals, was sold to a management team backed by Rutland Partners.

Corbett Keeling advised the management team on raising finance, structuring the transaction and negotiating terms.

Ashley House

Ashley House, specialists in funding the design and development of flexible and effective health and care properties, raised and refinanced equity and debt.

Corbett Keeling advised Ashley House on this financial restructuring and fund raising.

Five Rivers

Five Rivers, a provider of children’s fostering and care home services, raised debt funding and acquired a competitor.

Corbett Keeling advised Five Rivers.

Medpointe

Medpointe, the pharmaceuticals company, was bought by its management in a buy-out led by Carlyle Partners.

Corbett Keeling advised a co-investor to Carlyle Partners.